Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets U...

The approved product, used in treatment of patients with hypokalemia, is a generic version of Merck, Inc's Potassium Chloride extended-rele...

The tablet, a generic version of Upsher-Smith's Klor-Con extended release tablets, would be launched next month, said a press release here.

The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD), Lupin said.

Here is a list of top stocks that are likely to be in focus in today's trading session.

Lupin has received final approval from the US health regulator to market Potassium Chloride extended release capsules, used to treat potass...